Does DARBEPOETIN ALFA Cause Benign prostatic hyperplasia? 54 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Benign prostatic hyperplasia have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.2% of all adverse event reports for DARBEPOETIN ALFA.
54
Reports of Benign prostatic hyperplasia with DARBEPOETIN ALFA
0.2%
of all DARBEPOETIN ALFA reports
19
Deaths
53
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From DARBEPOETIN ALFA?
Of the 54 reports, 19 (35.2%) resulted in death, 53 (98.1%) required hospitalization, and 18 (33.3%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which DARBEPOETIN ALFA Alternatives Have Lower Benign prostatic hyperplasia Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE